Summit Securities Group’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q4
Hold
0
272
2020
Q3
Hold
0
168
2019
Q3
Sell
-6,000
Closed -$514K 157
2019
Q2
$514K Buy
+6,000
New +$514K 0.06% 68